Harlan and his brother, Chad Robins, found Adaptive TCR to meet the demand for this technology from academic institutions around the world.
Years: 2009
Propelling the Understanding of Adaptive Immunity
Dr. Harlan Robins, professor at the Fred Hutchinson Cancer Research Institute, and colleagues develop the first immunosequencing technology to profile the T-cell immune repertoire at scale and with precision, which had never before been possible.